LON: REDX 66.00GBX

Redx to Present at Jefferies London Healthcare Conference Redx Announces First Patient Dosed in Phase 2 Clinical Trial of RXC004 in Patients with Advanced Colorectal Cancer Redx Announces the Appointment of Dr Jane Griffiths, an Accomplished Pharma Industry Executive and Board Director, as Non-Executive Chair

About us
Our pipeline
Our science
- Our scientific publications
Investors
News & events
- News & events
Contact us
- Contact us
- Careers

About us
Our pipeline
Our science
- Our scientific publications
Investors
News & Events
- News & events
Contact
- Contact us
- Careers

Top suggestions

Redx to Present at Jefferies London Healthcare Conference
Redx Announces First Patient Dosed in Phase 2 Clinical Trial of RXC004 in Patients with Advanced Colorectal Cancer
Redx Announces the Appointment of Dr Jane Griffiths, an Accomplished Pharma Industry Executive and Board Director, as Non-Executive Chair

Presentations, analyst reports,
documents & videos

Latest Presentations

Analyst reports

Documents

Videos and webcasts

News & events

Our scientific publications

Investor centre

Contact us

RSS

Request e-mail alerts Register

Copyright © 2021 Redx Pharma Plc

Privacy & terms
Cookie policy

Website design & build by Carr Kamasa Design

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies. Cookie Policy.